15の証券会社がPrivia Health Groupに「中程度の買い」の評価を与え、取締役と機関投資家が株式を購入し、第3四半期のEPSは0.03ドルで、コンセンサス予想の0.05ドルを下回っています。 15 brokerages give Privia Health Group a "Moderate Buy" rating, directors and institutional investors purchase shares, Q3 EPS of $0.03 misses $0.05 consensus estimate.
Privia Health Group (NASDAQ: PRVA) は,平均1年目標価格24.79ドルの15のブローカーからコンセンサスで"適度な買い"の評価を受けています. Privia Health Group (NASDAQ: PRVA) has received a consensus "Moderate Buy" rating from 15 brokerages, with an average 1-year price target of $24.79. 最近のインサイダー取引には,取締役アダム・ボーラーとトーマス・A・マッカーシーが株式を購入し,カナダ年金制度投資委員会やNisa Investment Advisors LLCなどの機関投資家が会社に投資しています. Recent insider transactions include directors Adam Boehler and Thomas A. McCarthy purchasing shares, and institutional investors such as Canada Pension Plan Investment Board and Nisa Investment Advisors LLC have made investments in the company. Privia Health Groupは、第3四半期の利益が0.03ドルのEPSで、コンセンサス予想の0.05ドルを0.02ドル下回り、売上高は4億2,230万ドルでした。 Privia Health Group reported Q3 earnings of $0.03 EPS, missing the consensus estimate of $0.05 by $0.02, and revenue of $422.30 million.